Latest News

Image description

Cota expands Novartis agreement

Joint arrangement expected to allow Novartis to accelerate clinical development of new therapies for breast cancer and identify which patients will benefit most.

Image description

House GOP pulls ACA replacement bill ahead of vote

After a week spent trying to whip the 215 votes needed to pass the American Health Care Act, Republican leadership withdrew the bill from consideration Friday afternoon, sending the House into recess and leaving the Affordable Care Act in place.

Image description

FDA fast-tracks Genentech’s Rituxan

Drug is intended for the treatment of pemphigus vulgaris, a painful, disfiguring and potentially fatal autoimmune disease characterized by progressive blistering of skin and/or mucous membranes.